131 related articles for article (PubMed ID: 1889973)
1. Removal of silicon, aluminum and beta 2-microglobulin in chronic haemodialysis patients.
Hosokawa S; Yoshida O
Int Urol Nephrol; 1991; 23(3):281-4. PubMed ID: 1889973
[TBL] [Abstract][Full Text] [Related]
2. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
Sulková S; Lapcík O; Votruba T
Cas Lek Cesk; 1989 Apr; 128(17):520-3. PubMed ID: 2665936
[TBL] [Abstract][Full Text] [Related]
3. Silicon in chronic hemodialysis patients.
Hosokawa S; Morinaga M; Nishitani H; Maeda T; Yoshida O
ASAIO Trans; 1987; 33(3):260-4. PubMed ID: 3314921
[No Abstract] [Full Text] [Related]
4. Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m).
Ono T; Iwamoto N; Kataoka H; Yamada S; Sakai Y; Kunitomo T
ASAIO Trans; 1988; 34(3):342-5. PubMed ID: 3058179
[TBL] [Abstract][Full Text] [Related]
5. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
6. A new polymethylmethacrylate membrane for hemodialysis.
Bonomini M; Fiederling B; Bucciarelli T; Manfrini V; Di Ilio C; Albertazzi A
Int J Artif Organs; 1996 Apr; 19(4):232-9. PubMed ID: 8786174
[TBL] [Abstract][Full Text] [Related]
7. The effect of hollow-fiber dialyzer Plivadial Altra-Flux 140 on beta-2-microglobulin removal.
Kes P; Zubcić A; Ratković-Gusić I; Prsa M; Sefer S
Acta Med Croatica; 1997; 51(2):105-9. PubMed ID: 9204596
[TBL] [Abstract][Full Text] [Related]
8. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
9. [Changes in the beta 2-microglobulin level during hemodialysis].
Nikitinskaia LP; Stetsiuk EA; Iarmolinskiĭ IS; Barinov AV; Kon'kova TA
Urol Nefrol (Mosk); 1990; (5):29-31. PubMed ID: 2264202
[TBL] [Abstract][Full Text] [Related]
10. Effects of dialysis membranes on beta 2-microglobulin production and cellular expression.
Zaoui PM; Stone WJ; Hakim RM
Kidney Int; 1990 Nov; 38(5):962-8. PubMed ID: 2266681
[TBL] [Abstract][Full Text] [Related]
11. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
Szepietowski T; el-Hayek A
Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
13. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
[TBL] [Abstract][Full Text] [Related]
14. Long-term multicentre study on beta 2-microglobulin removal by PMMA BK membrane.
Arakawa M
Nephrol Dial Transplant; 1991; 6 Suppl 2():69-74. PubMed ID: 1866073
[TBL] [Abstract][Full Text] [Related]
15. Effect of dialyzer reprocessing with Renalin on serum beta-2-microglobulin and complement activation in hemodialysis patients.
Westhuyzen J; Foreman K; Battistutta D; Saltissi D; Fleming SJ
Am J Nephrol; 1992; 12(1-2):29-36. PubMed ID: 1415362
[TBL] [Abstract][Full Text] [Related]
16. Serum vanadium levels in chronic hemodialysis patients.
Hosokawa S; Yoshida O
Nephron; 1993; 64(3):388-94. PubMed ID: 8341383
[TBL] [Abstract][Full Text] [Related]
17. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
Sulková S; Votruba T; Lapcík O; Válek A
Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression.
Zaoui P; Green W; Hakim RM
Kidney Int; 1991 May; 39(5):1020-6. PubMed ID: 2067197
[TBL] [Abstract][Full Text] [Related]
20. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
Valeri A; Radhakrishnan J; Ryan R; Powell D
Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
